Healthcare -
Biotechnology - NASDAQ - US
$ 6.295
-0.71 %
$ 430 M
Market Cap
-1.1
P/E
PHAT - OTHER CURRENT LIABILITIES
Other Current Liabilities PHAT - Phathom Pharmaceuticals, Inc.
25.5 M
LAST VALUE
41.03%
2 YEAR CAGR
168.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR